NutriDex

The Supplement Research Compendium
🧠

Huperzine A

Huperzia serrata

Plant-derived cholinesterase inhibitor marketed for memory.

Mixed evidence 🧠Nootropic

✚ Updated · How we grade evidence

Evidence tier
Mixed
Research weight
Citations
6 verified / 6
Classification
Nootropic
❝
What the evidence says. Graded mixed: numerous Chinese RCTs and their meta-analyses report cognitive gains in Alzheimer's, but nearly all carry a high risk of bias, and the one rigorous NIH-funded US trial found no benefit on its primary endpoint. So the signal is unconvincing and likely inflated by low study quality. (Mixed evidence: Conflicting results across studies; benefit uncertain.)

What is Huperzine A?

Huperzine A (Huperzia serrata) is a nootropic used for memory support. NutriDex grades the human evidence as Mixed. Huperzine A is an alkaloid from the firmoss Huperzia serrata that, like donepezil, reversibly blocks acetylcholinesterase and crosses the blood-brain barrier. Chinese meta-analyses of Alzheimer's and vascular dementia trials report meaningful gains on the MMSE (mean differences of roughly 2.9–3.8 points versus placebo) plus better daily function, and a meta-analysis in schizophrenia found improved memory scores when added to antipsychotics. The major caveat is quality: almost all trials were small, short, conducted in China, and rated high risk of bias. The single rigorous, NIH-funded US trial (210 patients) found no cognitive benefit at 200 mcg twice daily on its primary endpoint. There is little credible evidence it sharpens memory in healthy adults. Overall the effect, if real, is modest and far from established by Western trial standards.

Purported Benefits

✓Memory support
✓Cognition in dementia (claimed)
✓Acetylcholine boost
✓Adjunct in schizophrenia (claimed)

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Cognition in dementia (MMSE)Chinese meta-analyses show ~3-4 MMSE point gains but nearly all trials are high risk of bias. Mixed ↔ mixed · moderate 2
Alzheimer's cognition (rigorous trial)The one NIH-funded US RCT (n=210) found no ADAS-Cog benefit at 200 mcg BID. Moderate — no effect · negligible 1
Adjunct memory in schizophreniaMeta-analysis of 12 RCTs found improved memory added to antipsychotics, but all trials in China. Preliminary ↑ benefit · moderate 1
Memory in healthy adultsOnly a 1999 adolescent matched-pair trial supports this; little credible evidence in healthy adults. Preliminary ↑ benefit · moderate 1

Dosing & Compounds

Typical Dose
Studied at 100–200 mcg once or twice daily; AD trials used up to 400 mcg twice daily.
Active Compounds
Huperzine A (a sesquiterpene alkaloid)

Safety & Cautions

As a cholinesterase inhibitor, huperzine A can cause cholinergic side effects: nausea, vomiting, diarrhea, sweating, hypersalivation, dizziness, muscle twitching and, rarely, slowed heart rate or arrhythmia. Do not combine with prescription cholinesterase inhibitors (donepezil, rivastigmine, galantamine) or other cholinergic drugs, as effects are additive; use caution with anticholinergics, beta-blockers and bradycardic agents, and in asthma, COPD, peptic ulcer, seizure or slow-heart-rhythm disorders. Avoid in pregnancy and breastfeeding due to lack of safety data. Supplement potency is unregulated and often inconsistent. Educational only — always check with your doctor or pharmacist before combining Huperzine A with any medicine.

Key Studies

Meta-analysis Zheng 2016 ✓ Full text
Meta-analysis of 12 RCTs (n=1117) in schizophrenia: adjunctive huperzine A improved memory and IQ scores vs control; all trials in China.
Meta-analysis Yang 2013 ✓ PubMed
Meta-analysis of 20 RCTs (n=1823): MMSE ~3.75 points higher vs placebo at 8 wk, but most trials at high risk of bias.
Meta-analysis Xing 2014 ✓ PubMed
Meta-analysis (8 AD trials n=733, 2 vascular-dementia trials n=92): improved MMSE and ADL; adverse effects mild and transient.
Systematic review Yang 2013 (PLoS One) ✓ Full text
Systematic review concludes apparent benefit on cognition and daily living, but cautions findings are undermined by poor trial methodology.
RCT Rafii 2011 ✓ PubMed
NIH/ADCS phase II RCT (n=210): huperzine A 200 mcg BID showed NO ADAS-Cog benefit vs placebo at 16 weeks (Class III, negative).
RCT Sun 1999 ✓ PubMed
Double-blind matched-pair trial in 34 adolescent pairs: 100 mcg/day raised memory quotient (115 vs 104 placebo, P<0.01) over 4 weeks.
6 sources cited · 6 verified Search all studies on PubMed ↗

Common questions about Huperzine A

What is Huperzine A used for?

Huperzine A is most often taken for Memory support, Cognition in dementia (claimed), Acetylcholine boost, Adjunct in schizophrenia (claimed). Plant-derived cholinesterase inhibitor marketed for memory.

Does Huperzine A work — what does the evidence say?

Mixed evidence. Conflicting results across studies; benefit uncertain. Huperzine A is an alkaloid from the firmoss Huperzia serrata that, like donepezil, reversibly blocks acetylcholinesterase and crosses the blood-brain barrier. Chinese meta-analyses of Alzheimer's and vascular dementia trials report meaningful gains on the MMSE (mean differences of roughly 2.9–3.8 points versus placebo) plus better daily function, and a meta-analysis in schizophrenia found improved memory scores when added to antipsychotics. The major caveat is quality: almost all trials were small, short, conducted in China, and rated high risk of bias. The single rigorous, NIH-funded US trial (210 patients) found no cognitive benefit at 200 mcg twice daily on its primary endpoint. There is little credible evidence it sharpens memory in healthy adults. Overall the effect, if real, is modest and far from established by Western trial standards.

What is the typical dose of Huperzine A?

Studied at 100–200 mcg once or twice daily; AD trials used up to 400 mcg twice daily.

Is Huperzine A safe? Any cautions or side effects?

As a cholinesterase inhibitor, huperzine A can cause cholinergic side effects: nausea, vomiting, diarrhea, sweating, hypersalivation, dizziness, muscle twitching and, rarely, slowed heart rate or arrhythmia. Do not combine with prescription cholinesterase inhibitors (donepezil, rivastigmine, galantamine) or other cholinergic drugs, as effects are additive; use caution with anticholinergics, beta-blockers and bradycardic agents, and in asthma, COPD, peptic ulcer, seizure or slow-heart-rhythm disorders. Avoid in pregnancy and breastfeeding due to lack of safety data. Supplement potency is unregulated and often inconsistent.

How many studies support Huperzine A?

NutriDex cites 6 sources for Huperzine A, graded "Mixed".

Cite this page
APA

Peh, D. (2026). Huperzine A (Huperzia serrata): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/huperzine-a

BibTeX
@misc{nutridex_huperzine_a,
  author       = {Peh, Daryl},
  title        = {Huperzine A (Huperzia serrata): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/huperzine-a},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances